Customer engagement in pharma is shifting permanently toward remote and digital, with telehealth use now 38x pre-pandemic levels and 40% of patients relying on apps for treatment support. The industry saw 500% growth in digital/remote HCP engagement after a 75% global drop in promotional activity early in COVID-19. To thrive, companies must orchestrate engagement strategies with Next Best guidance, leverage local thought leaders to drive practice change, and build patient communities for stronger connections. This integrated approach accelerates impact, strengthens trust, and supports long-term competitive advantage.

Join for free to read